MediPharm Labs (TSX:LABS) Total Liabilities : C$11.39 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is MediPharm Labs Total Liabilities?

MediPharm Labs's Total Liabilities for the quarter that ended in Mar. 2024 was C$11.39 Mil.

MediPharm Labs's quarterly Total Liabilities declined from Sep. 2023 (C$12.80 Mil) to Dec. 2023 (C$10.93 Mil) but then increased from Dec. 2023 (C$10.93 Mil) to Mar. 2024 (C$11.39 Mil).

MediPharm Labs's annual Total Liabilities increased from Dec. 2021 (C$9.22 Mil) to Dec. 2022 (C$9.49 Mil) and increased from Dec. 2022 (C$9.49 Mil) to Dec. 2023 (C$10.93 Mil).

MediPharm Labs Total Liabilities Historical Data

The historical data trend for MediPharm Labs's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediPharm Labs Total Liabilities Chart

MediPharm Labs Annual Data

Trend

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

37.60

39.82

9.22

9.49

10.93

MediPharm Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															8.39	14.51	12.80	10.93	11.39

MediPharm Labs Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

MediPharm Labs's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	10.863	+	(0.069	+	8.3266726846887E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	10.93

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	63.937	-	53.005
	=	10.93

MediPharm Labs's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	11.332	+	(0.058	+	-1.7347234759768E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	11.39

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	61.245	-	49.855
	=	11.39

MediPharm Labs Total Liabilities Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

MediPharm Labs (TSX:LABS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (TSX:LABS) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

MEDIF:USA MLZ:Germany

Address

151 John Street, Barrie, ON, CAN, L4N 2L1

Website

https://www.medipharmlabs.com

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.

Executives

Keith Strachan

Director